Honda、EV用バッテリー研究開発会社SESと共同開発契約を締結

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

2022年01月19日 11時00分

Source: Honda Motor Co, Ltd

Honda、EV用バッテリー研究開発会社SESと共同開発契約を締結

東京, 2022年01月19日 - (JCN Newswire) - Hondaは、EV用バッテリー研究開発会社であるSES Holdings Pte. Ltd.（本社：米国ボストン、以下、SES）と、2021年12月にリチウム金属二次電池※1に関する共同開発契約を締結しました。

またSESは、SPAC（特別買収目的会社）スキームによるニューヨーク証券取引所（以下、NYSE）への株式上場を予定しており、Hondaは、SPACの私募増資引き受け（PIPE）を通じて、NYSEに上場するSES AI Corporationの約２％の株式を取得する予定※２ ※3です。

Hondaはグローバルでの電動化に向けた取り組みを加速する中で、EVの基幹部品であるバッテリーについては、独自に開発している全固体電池を含めて、次世代バッテリーとしていくつかの選択肢を並行して検討しており、今回の共同開発契約はその一環です。

今後、HondaとSESは、安全で高い耐久性をもつ大容量のEV用次世代バッテリーの実現に向けて、共同研究を進めていきます。

本リリースの詳細は下記をご参照ください。
https://www.honda.co.jp/news/2022/c220119a.html

概要：本田技研工業株式会社

詳細は www.honda.co.jp をご覧ください。

Source: Honda Motor Co, Ltd
セクター: 自動車

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

CleverTap

CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 22:42 JST

Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Nov 22, 2024 11:00 JST

NaaS Technology Inc.

NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST

Honda Motor Co, Ltd

Honda Unveils Demonstration Production Line for All-Solid-State Batteries Located in Sakura City, Tochigi Prefecture, Japan
Nov 21, 2024 15:35 JST

Deadline to Lead in Securities Fraud Lawsuit Against Humacyte, Inc. (HUMA) is January 17, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Nov 21, 2024 09:00 JST

Lexaria Bioscience

ALL Study Groups Using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
Nov 20, 2024 23:05 JST

Mitsubishi Heavy Industries, Ltd.

Start of Demonstration Test of Two-Phase Direct-to-Chip Cooling in the Air-Cooled Data Center
Nov 20, 2024 15:30 JST

Eisai

Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
Nov 20, 2024 11:51 JST

Eisai

Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements
Nov 20, 2024 10:24 JST

Kingsoft Corporation Limited

Kingsoft Announces 2024 Third Quarter Results
Nov 19, 2024 18:54 JST

Olympus

NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Nov 19, 2024 15:30 JST

Supercomputer Fugaku retains first place worldwide in HPCG and Graph500 rankings
Nov 19, 2024 09:02 JST

CleverTap

CleverTap Recognized as a Strong Performer in Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 18, 2024 23:30 JST

NEC Corporation

World's First Successful Trial of Quantum Tokens Created Using Quantum Technology
Nov 18, 2024 17:29 JST

Fujitsu and SAP Fioneer enter partnership to accelerate digital transformation in the insurance industry and deliver services that contribute to customers' sustainable business
Nov 18, 2024 12:31 JST

Toyota Motor Corporation

Expanding Possibilities with the Liquid Hydrogen-Powered GR Corolla in the Season Final Round
Nov 18, 2024 09:25 JST

COP29: Indonesian Special Envoy Hashim Djojohadikusumo Announces EUR 1,2 Billion Green Funding
Nov 16, 2024 18:00 JST

Mitsubishi Heavy Industries, Ltd.

Mitsubishi Shipbuilding Holds Christening and Launch Ceremony of LNG-Powered Roll-on/Roll-off Ship TRANS HARMONY EMERALD in Shimonoseki
Nov 15, 2024 18:58 JST

Eisai

Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
Nov 15, 2024 17:33 JST

Eisai

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Nov 15, 2024 14:31 JST

More Latest Release >>